Compare HPQ & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HPQ | RMD |
|---|---|---|
| Founded | 1939 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 33.6B |
| IPO Year | 2002 | 1996 |
| Metric | HPQ | RMD |
|---|---|---|
| Price | $33.45 | $253.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 20 |
| Target Price | $27.31 | ★ $251.99 |
| AVG Volume (30 Days) | ★ 10.6M | 855.7K |
| Earning Date | 11-24-2026 | 10-29-2026 |
| Dividend Yield | ★ 3.56% | 1.04% |
| EPS Growth | N/A | ★ 9.67 |
| EPS | 1.79 | ★ 10.43 |
| Revenue | ★ $55,295,000,000.00 | $2,957,013,000.00 |
| Revenue This Year | $8.24 | $2.59 |
| Revenue Next Year | $0.15 | $6.92 |
| P/E Ratio | ★ $18.84 | $24.23 |
| Revenue Growth | 3.24 | ★ 13.44 |
| 52 Week Low | $17.56 | $180.27 |
| 52 Week High | $36.23 | $277.67 |
| Indicator | HPQ | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 60.02 | 76.81 |
| Support Level | $30.60 | $247.01 |
| Resistance Level | $36.23 | $262.16 |
| Average True Range (ATR) | 1.25 | 5.43 |
| MACD | 0.24 | 2.44 |
| Stochastic Oscillator | 82.94 | 94.16 |
HP is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one-third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.